Vivos Therapeutics (VVOS) Shares Outstanding (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Shares Outstanding (Entity) of $13.5 million for Q1 2026, up 56.9% year-over-year from $8.6 million in Q1 2025, and up 45.22% quarter-over-quarter from $9.3 million in Q4 2025.
Vivos Therapeutics (VVOS) Shares Outstanding (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Shares Outstanding (Entity) for 8 consecutive years, with $13.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 56.9% year-over-year to $13.5 million; the TTM figure through Mar 2026 stood at $13.5 million (up 56.9% YoY), while the FY2025 annual figure was $9.3 million, up 57.68% from the prior year.
- Shares Outstanding (Entity) climbed to $13.5 million in Q1 2026 per VVOS's latest filing, from $9.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $920.5 million in Q4 2022 and bottomed at $920485.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $158.4 million across 5 years, with a median of $6.6 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 99899.97% — and 2023, when it sank 99.87%.
- Vivos Therapeutics' Shares Outstanding (Entity) stood at $920.5 million in 2022, then tumbled by 99.87% to $1.2 million in 2023, then soared by 382.99% to $5.9 million in 2024, then jumped by 57.68% to $9.3 million in 2025, then surged by 45.22% to $13.5 million in 2026.
- Business Quant data shows VVOS's Shares Outstanding (Entity) at $13.5 million in Q1 2026, $9.3 million in Q4 2025, and $11.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Vivos Therapeutics | 4.96 Mn | 3.16 Mn | 2.95 Mn | 17.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.63 Mn |
| Dec 31, 2025 | 10.27 Mn |
| Sep 30, 2025 | 10.96 Mn |
| Jun 30, 2025 | 9.09 Mn |
| Mar 31, 2025 | 8.60 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | 6.62 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 990,562.00 |
| Dec 31, 2022 | 920.48 Mn |
| Sep 30, 2022 | 849.34 Mn |
| Jun 30, 2022 | 849.34 Mn |
| Mar 31, 2022 | 849,320.00 |
| Dec 31, 2021 | 849,320.00 |
| Sep 30, 2021 | 833,060.00 |
| Jun 30, 2021 | 829,521.00 |